Your session is about to expire
← Back to Search
3-Day Partial Breast Radiation for Breast Cancer
Study Summary
This trial is testing if a higher does of radiation given over a shorter period is just as effective and has fewer side effects than the standard lower does given over a longer period.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 200 Patients • NCT02526498Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am fully active or can carry out light work.My breast cancer surgery showed signs of cancer in the lymph vessels.My breast cancer is of the invasive lobular type.I do not have uncontrolled infections, diabetes, or connective tissue diseases that would make treatment risky.I am not currently on any experimental treatments.The cancer has spread beyond the edges of the main tumor and makes up at least 25% of the tumor area.I do not have an active cancer other than non-melanoma skin cancer, or my doctor believes my relapse risk is below 5% in the next 3 years.I am aged 40-49, with no breast biopsies, atypia, LCIS history, or family history of breast cancer.Clips were placed in my surgery area to help guide future treatments.I have not been tested for BRCA mutations, or if tested, I am not a carrier.I am enrolled or plan to enroll in another treatment study for my breast cancer.I have had radiation therapy on the same or opposite side of my chest before.There is a lot of evidence showing that the cancer has spread through the lymph vessels.I have had cosmetic or reconstructive surgery on my breast.My breast cancer is in an early stage, not spread, and the tumor is smaller than 3cm.I am female.I am female.My breast cancer is widespread or in multiple areas.My cancer has spread to distant parts of my body.My Oncotype DX breast cancer test score is 26 or higher.I am 45 years old or older.I haven't had cancer treatments other than bisphosphonates, hormonal therapies, or anti-HER2 therapies in the last 2 weeks.My final surgery samples show no cancer at the edges or no cancer at all.I am using two birth control methods or am not able to have children, and will inform my doctor if I become pregnant.My cancer surgery cut very close to the cancer cells.I am not pregnant and can become pregnant but have taken a test confirming this within the last 14 days.My breast cancer was small (<=5cm) before treatment and no cancer in lymph nodes after.My breast cancer risk score is high.
- Group 1: Participants with Breast Cancer
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current capacity of this clinical trial's participant pool?
"Affirmative. According to the data hosted on clinicaltrials.gov, this medical study is presently recruiting participants. The trial was initially posted in August 2019 and updated lastly in October 2022; it requires 140 subjects from 12 sites for successful completion of the project."
How many sites are in charge of managing this research endeavor?
"Through the course of this medical trial, 12 different hospitals are participating. These include Memorial Sloan Kettering Basking Ridge in Basking Ridge and two Memoral Sloan Kettering Monmouth locations (Middletown & Uniondale), as well as other healthcare institutions."
Has the FDA given clearance for Accelerated Partial Breast Irradiation?
"Our team at Power assessed the safety of Accelerated Partial Breast Irradiation to be a 2, as this is still in Phase 2. This means that while there have been some data showing safety, efficacy has yet to be conclusively proven."
Are there any vacancies remaining for the trial?
"The information hosted on clinicaltrials.gov indicates this trial is currently in need of enrollees, with the first posting date being August 30th 2019 and a recent update occuring October 4th 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger